Trial Profile
RE-implantation of CYpher stent for Cypher in-Lesion restenosis.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 Aug 2011
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms RECYCLE
- 18 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 19 Feb 2011 New trial record